Diabetic Nephropathy: Novel Molecular Mechanisms and Therapeutic Avenues.
作者信息
Oltean Sebastian, Coward Richard, Collino Massimo, Baelde Hans
机构信息
Institute of Biomedical & Clinical Sciences, University of Exeter Medical School, Exeter EX1 2LU, UK.
Bristol Renal, Translational Health Sciences, Bristol Medical School, Bristol University, Bristol BS8 1TD, UK.
出版信息
Biomed Res Int. 2017;2017:3146524. doi: 10.1155/2017/3146524. Epub 2017 Nov 22.
Abstract
摘要
相似文献
1
Diabetic Nephropathy: Novel Molecular Mechanisms and Therapeutic Avenues.糖尿病肾病：新的分子机制与治疗途径
Biomed Res Int. 2017;2017:3146524. doi: 10.1155/2017/3146524. Epub 2017 Nov 22.
2
Comment on: Lin et al. (2007) SUMO4 M55V variant is associated with diabetic nephropathy in type 2 diabetes: Diabetes 56: 1177-1180.评论：林等人（2007年）：SUMO4 M55V变异体与2型糖尿病中的糖尿病肾病相关：《糖尿病》56卷：1177 - 1180页
Diabetes. 2007 Aug;56(8):e11; author reply e12-3. doi: 10.2337/db07-0237.
3
Are SGLT2 Inhibitors Ready for Prime Time for CKD?钠-葡萄糖协同转运蛋白2抑制剂对慢性肾脏病而言已准备好进入黄金时期了吗？
Clin J Am Soc Nephrol. 2018 Feb 7;13(2):318-320. doi: 10.2215/CJN.07680717. Epub 2017 Sep 11.
4
Diabetes, heart failure, and renal dysfunction: The vicious circles.糖尿病、心力衰竭和肾功能障碍：恶性循环。
Prog Cardiovasc Dis. 2019 Jul-Aug;62(4):298-302. doi: 10.1016/j.pcad.2019.07.003. Epub 2019 Aug 1.
5
Inflammatory cytokines in diabetic nephropathy.糖尿病肾病中的炎性细胞因子。
J Diabetes Res. 2015;2015:948417. doi: 10.1155/2015/948417. Epub 2015 Feb 15.
6
Bariatric surgery and kidney disease outcomes in severely obese youth.重度肥胖青少年的减肥手术与肾脏疾病转归
Semin Pediatr Surg. 2020 Feb;29(1):150883. doi: 10.1016/j.sempedsurg.2020.150883. Epub 2020 Jan 20.
7
Aquaporin 11 variant associates with kidney disease in type 2 diabetic patients.水通道蛋白11变体与2型糖尿病患者的肾脏疾病相关。
Am J Physiol Renal Physiol. 2016 Mar 1;310(5):F416-25. doi: 10.1152/ajprenal.00295.2015. Epub 2015 Dec 30.
8
A novel role of LRP5 in tubulointerstitial fibrosis through activating TGF-β/Smad signaling.LRP5 在肾小管间质纤维化中的新作用是通过激活 TGF-β/Smad 信号通路实现的。
Signal Transduct Target Ther. 2020 Apr 29;5(1):45. doi: 10.1038/s41392-020-0142-x.
9
Guideline-directed medical therapies (GDMTs) for chronic kidney disease with type 2 diabetes (CKD + T2D): Translation of lessons learned from the management of heart failure.2型糖尿病合并慢性肾脏病（CKD+T2D）的指南指导药物治疗（GDMTs）：心力衰竭管理经验的转化
J Diabetes Complications. 2025 Apr;39(4):108985. doi: 10.1016/j.jdiacomp.2025.108985. Epub 2025 Mar 1.
10
The Iron-Klotho-VDR Axis Is a Major Determinant of Proximal Convoluted Tubule Injury in Haptoglobin 2-2 Genotype Diabetic Nephropathy Patients and Mice.铁调素-Klotho-VDR 轴是糖化血红蛋白 2-2 基因型糖尿病肾病患者和小鼠近端曲管损伤的主要决定因素。
J Diabetes Res. 2018 Sep 3;2018:7163652. doi: 10.1155/2018/7163652. eCollection 2018.
引用本文的文献
1
The Key Role of Nutritional Intervention in Delaying Disease Progression and the Therapeutic Management of Diabetic Kidney Disease-A Challenge for Physicians and Patients.营养干预在延缓疾病进展及糖尿病肾病治疗管理中的关键作用——对医生和患者的挑战
J Pers Med. 2024 Jul 23;14(8):778. doi: 10.3390/jpm14080778.
2
Functioning and mechanisms of PTMs in renal diseases.蛋白质翻译后修饰在肾脏疾病中的作用及机制。
Front Pharmacol. 2023 Nov 21;14:1238706. doi: 10.3389/fphar.2023.1238706. eCollection 2023.
3
Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review).NLRP3 炎性小体通路抑制剂作为炎症性疾病有希望的治疗候选物（综述）。
Int J Mol Med. 2023 Apr;51(4). doi: 10.3892/ijmm.2023.5238. Epub 2023 Mar 24.
4
Novel glucose-responsive nanoparticles based on p-hydroxyphenethyl anisate and 3-acrylamidophenylboronic acid reduce blood glucose and ameliorate diabetic nephropathy.基于对羟基苯乙基茴香酸和3-丙烯酰胺基苯硼酸的新型葡萄糖响应性纳米颗粒可降低血糖并改善糖尿病肾病。
Mater Today Bio. 2021 Dec 3;13:100181. doi: 10.1016/j.mtbio.2021.100181. eCollection 2022 Jan.
5
The Role of Finerenone in the Management of Diabetic Nephropathy.非奈利酮在糖尿病肾病管理中的作用
Diabetes Ther. 2021 Jul;12(7):1791-1797. doi: 10.1007/s13300-021-01085-z. Epub 2021 May 29.
6
Silencing of miR-150-5p Ameliorates Diabetic Nephropathy by Targeting SIRT1/p53/AMPK Pathway.通过靶向SIRT1/p53/AMPK途径沉默miR-150-5p可改善糖尿病肾病
Front Physiol. 2021 Apr 9;12:624989. doi: 10.3389/fphys.2021.624989. eCollection 2021.
7
Diabetic Nephropathy - a Review of Risk Factors, Progression, Mechanism, and Dietary Management.糖尿病肾病——危险因素、进展、机制及饮食管理综述
Biomol Ther (Seoul). 2021 Jul 1;29(4):365-372. doi: 10.4062/biomolther.2020.204.
8
Diabetic nephropathy: recent advances in pathophysiology and challenges in dietary management.糖尿病肾病：病理生理学的最新进展及饮食管理面临的挑战
Diabetol Metab Syndr. 2019 Jan 23;11:7. doi: 10.1186/s13098-019-0403-4. eCollection 2019.
Zotero 插件